|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Deferred tax expenses (benefits) | |||||
| Amortization of debt discount | |||||
| Amortization of operating lease ROU asset | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued payroll and related expenses | |||||
| Net deferred revenue on shipments to distributors | |||||
| Deferred service revenue | |||||
| Net change in operating lease liability | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of PP&E including software and website development | |||||
| Proceeds from tenant improvements allowance | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Common stock repurchased and related expenses | |||||
| Proceeds from subordinated convertible notes payable | |||||
| Repayments of note payable | |||||
| Proceeds from subordinated convertible notes payable – related party | |||||
| Acquisition of common stock for tax withholding obligations | |||||
| Proceeds from stock options exercised | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Cash paid for interest | |||||
Loading...